cACP-DeepGram
'cACP-DeepGram' is a software tool designed to address the challenges associated with cancer treatment using anticancer peptides (ACPs). Cancer is a significant global health concern characterized by irregular cellular growth and division, and traditional approaches to treat it, such as therapies and wet laboratory-based methods, can be costly and have diverse side effects. ACPs have garnered attention as a more selective and effective approach to cancer treatment, as they can target and treat cancer cells without harming normal cells.
The rapid increase in peptide sequences poses a challenge in accurately predicting the potential of ACPs for cancer treatment. 'cACP-DeepGram' aims to provide a reliable prediction model for ACPs. It employs a FastText-based word embedding strategy to represent each peptide sample through a skip-gram model. Once the peptide embedding descriptors are extracted, a deep neural network (DNN) model is applied to discriminate ACPs.
The optimized parameters of the DNN model achieved high prediction accuracy, with 96.94% accuracy in training samples, 93.41% accuracy in alternate samples, and 94.02% accuracy in independent samples.
Topic
Small molecules;Machine learning;Oncology;Drug discovery
Detail
Software interface: Library,Script
Language: C++,C,MATLAB
License: Not stated
Cost: Free
Version name: -
Credit: -
Input: -
Output: -
Contact: Maqsood Hayat m.hayat@awkum.edu.pk
Collection: -
Maturity: -
Publications
- cACP-DeepGram: Classification of anticancer peptides via deep neural network and skip-gram-based word embedding model.
- Akbar S, et al. cACP-DeepGram: Classification of anticancer peptides via deep neural network and skip-gram-based word embedding model. cACP-DeepGram: Classification of anticancer peptides via deep neural network and skip-gram-based word embedding model. 2022; 131:102349. doi: 10.1016/j.artmed.2022.102349
- https://doi.org/10.1016/J.ARTMED.2022.102349
- PMID: 36100346
- PMC: -
Download and documentation
< Back to DB search